10-K/A

AMENDMENT NO. 1 TO FORM 10-K

Company: LIGAND PHARMACEUTICALS INC
Filed: May 16, 2012
Period of Report: December 31, 2011
Accession Number: 0001193125-12-236832

View Document ↗ View on SEC.gov ↗